Northern Ireland Cancer Trials Network Logo
  • Home
  • About Us
    • Staff
    • Facilities
    • Location
    • NICTN Publications
    • Related Links
  • Getting Involved
  • Working With Us
  • Trials & Studies
    • Portfolio – Open Trials
    • By Cancer Type
    • By Hospital
    • Trials With Results
  • Contact Us
  • Menu
Northern Ireland Cancer Trials Network > PRiZM+

PRiZM+

Trial PRiZM+
Cancer Type Haematological Cancers and Lymphoma
Hospital(s) Belfast City Hospital
Information

A phase II platform study of zanubrutinib monotherapy and combination therapy for relapsed and refractory primary CNS lymphoma

Click Here to view CancerHelpUK trial summary
ShareEmail this to someone
email
Share on Facebook
Facebook
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin
Share on Google+
Google+
Posted in .

Post navigation

← NERO
Bayer 21343 →

Contact Details

Northern Ireland Cancer Trials Network
East Podium, C Floor
Co-ordinating Centre
Belfast City Hospital
51 Lisburn Road
Belfast BT9 7AB

Phone: +44 (0) 28 9615 2652
Email: nictn@belfasttrust.hscni.net

Co-ordinating and promoting cancer clinical trial activity throughout Northern Ireland
A SiteOrigin Theme